[Complement activation in heparin--plasma inhibitory effect of anticoagulants on serum complement activation, 2nd report].
Our previous study of the inhibitory effect of EDTA and citrate in plasma on complement activation revealed that complement is activated in usual citrate plasma but not in usual EDTA plasma. The present study is a similar one using other anticoagulants containing heparin. CH50 and activities of C4 and C2 were assayed in serum or plasma containing various concentrations of anticoagulant after incubation with latex particles bearing immunoglobulin(Ig-Latex). It was found that complement activation is inhibited by heparin in a dose-dependent manner and that 10 U/ml of heparin does not inhibit CH50 reduction and C2 inactivation but inhibit C4 inactivation partially, indicating that complement activation proceeds in plasma containing usual concentration of heparin. Similar results were obtained in cases of low molecular weight heparin(LMWH) and nafamostat mesilate(Futhan). Complement activation was not inhibited by gabexate mesilate(FOY) in the tested range of concentrations. Thus, it was revealed that complement activation is not inhibited by usual concentrations of heparin, LMWH, Futhan and FOY.
Kobayashi
E
E
Department of Medical Technology, Osaka Prefectural College of Health Sciences, Habikino.
Kitano
E
E
Kondo
H
H
Kitamura
H
H
D000328:Adult; D000925:Anticoagulants / Q000494:pharmacology*; D003167:Complement Activation / Q000187:drug effects*; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques
D000925:Anticoagulants; D006493:Heparin